Navigation Links
51st Food and Drug Law Institute Annual Conference Focuses on Relationship Between Scientific Advances and FDA Law & Regulation

U.S. Supreme Court Justice Antonin Scalia, FDA Commissioner Andrew C. von Eschenbach Among Featured Speakers at March 26-27, 2008, FDLI/FDA Meeting in Washington, D.C.

WASHINGTON, Jan. 9 /PRNewswire-USNewswire/ -- The Food and Drug Law Institute's 51st Annual Conference, co-sponsored with the Food and Drug Administration, will focus on the interrelationship between scientific and technological advances and food & drug law & regulation.

FDLI/FDA's March 26-27, 2008 meeting at the L'Enfant Plaza Hotel in Washington, D.C., will include a luncheon speech by U.S. Supreme Court Justice Antonin Scalia and a State of the FDA address by Commissioner Andrew C. von Eschenbach, M.D. Rep. John D. Dingell (D-Mich.) is also an invited featured speaker.

As noted in the recent FDA Science and Mission at Risk Report (, scientific advances often pose significant policy issues and challenges for legal and regulatory systems. While government agencies are authorized to develop and implement policies that stimulate scientific advances for the benefit of public health, they are also mandated to ensure safety, effectiveness and affordability. The FDLI annual meeting, Scientific Revolution and Legal Evolution: Keeping Pace with Science & Policy Issues in Food and Drug Law, focuses on these dynamic tensions while informing attendees about the impact of recent wide-sweeping food and drug legislation.

Other featured speakers include:

J. Scott Ballenger, Partner, Latham & Watkins;

Brian J. Donato, Partner, Hyman, Phelps & McNamara;

Lillian J. Gill, Director, Office of Compliance, Centers for Devices and Radiological Health, FDA;

Jesse L. Goodman, M.D., Director, Center for Biologics Evaluation and Research, FDA;

Peter Barton Hutt, Partner, Covington & Burling;

Gerald F. Masoudi, Associate General Counsel, Food & Drug Division, Department of Health & Human Services;

Daniel Meron, General Counsel, Department of Health and Human Services;

Thomas Miller, Member, Managing Board, Siemens Medical Solutions;

Paula A. Monopoli, Professor, University of Maryland School of Law & Founding Director, Women, Leadership & Equality Program;

Lydia Parnes, Director, Office of Consumer Protection, Federal Trade Commission;

David Schmidt, President & CEO, International Food Information Council;

Barry M. Straube, M.D., Chief Medical Officer, Center for Medicare & Medicaid Services;

Daniel E. Troy, Partner, Sidley Austin;

Janet Woodcock, M.D., Deputy Commissioner and Chief Medical Officer, FDA; and

Julie Zawisza, Assistant Commissioner for Public Affairs, FDA.

For a complete list of speakers and agenda, visit

The Early Bird Rates, effective through Feb. 15, are:

Both One Day

Days Only

$945 $795 FDLI Members

$1,270 $1,020 Non-members

$395 $345 Government (Non-FDA, including FDAAA members who

are not currently employed)

$670 $470 Academics, 501(c)(3) Non-Profits

$399 $199 Full Time Students (Special discount: $350 for a

group of 5 or more who register for both days)

To register for the conference, visit or call (800)956-6923 or (202) 371-1420.

Founded in 1949, FDLI publishes the award-winning, peer-reviewed Food and Drug Law Journal; the bimonthly magazine Update; FDA Directory; and dozens of books and publications for attorneys, regulatory affairs practitioners, scientists, health care professionals, government employees and marketers in the food and drug field. For more information, visit

SOURCE Food and Drug Law Institute
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. DaVita and Phoenix-Based Southwest Kidney Institute Form Broad Partnership
2. MCG receives second-time designation from National Cancer Institute
3. Food and Drug Law Institute Sponsors Major Enforcement Conference
4. Food and Drug Law Institute, Project on Emerging Nanotechnologies Co-Sponsor Major Conference on Nanotechnology Law, Regulation and Policy
5. National Institute on Drug Abuse Director Nora Volkow Speaks about the Dangers of Narcotics on Azteca Americas Political Forum Issues: Caras y Voces
6. OHSU Cancer Institute researcher discovers what fuels certain cancer mutation
7. OHSU Cancer Institute researcher develops test for targeted therapy in acute myeloid leukemia
8. OHSU Cancer Institute research discovery opens new window to understanding chronic myeloid leukemia
9. Stem Cell Institute Correct in Rejecting Applications Over Conflicts of Interest; Institutions, Board Members Involved Must Be Identified, Consumer Advocates Say
10. The Roskamp Institute Receives Award of Appreciation for Its Continued Innovative and Technological Advances
11. EEG Institute to Provide Free Post-Traumatic Stress Treatment for Iraq and Afghanistan Veterans
Post Your Comments:
(Date:6/26/2016)... Charlotte, NC (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind ... able to be personalized through a fitness app. The fitness app plans to fix the ... solutions currently only offer a one size fits all type program , They ...
(Date:6/25/2016)... ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 ... brings up a new, often overlooked aspect of head lice: the parasite’s ability to live ... not a common occurrence, but a necessary one in the event that lice have simply ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has dedicated ... has implemented orthobiologic procedures as a method for treating his patients. The procedure ... doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may ... to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To ... for healthy coping following a traumatic event. , Trauma sufferers tend to feel a ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, ... Elite. The attorneys chosen by their peers for this recognition are considered among the ... Traurig Shareholders received special honors as members of this year’s Legal Elite Hall of ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Research and Markets has announced ... Forecast to 2022" report to their offering. ... the patients with kidney failure, it replaces the function of ... patient,s blood and thus the treatment helps to keep the ... balance. Increasing number of ESRD patients & ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: ... 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) assay ... sepsis or septic shock. With this clearance, Roche is ... a fully integrated solution for sepsis risk assessment and ... with bacterial infection and PCT levels in blood can ...
(Date:6/23/2016)... Bracket , a leading clinical trial technology and specialty ... Bracket eCOA (SM) 6.0, at the 52 nd ... in Philadelphia , Pennsylvania.  A demonstration of ... its kind to fully integrate with RTSM, will be held ... a flexible platform for electronic clinical outcomes assessments that is ...
Breaking Medicine Technology: